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Background: Evaluation of intraepithelial duodenal lymphocytosis (IDL) is important in celiac disease (CD). There is
no established cut-off value for increased number of IELs in the bulb.
We therefore investigated the relation between IEL counts in the bulb and duodenal specimens in non-celiac
subjects.
Methods: The number of CD3+ IELs was determined in specimens from the second part of the duodenum and
from the bulb in 34 non-celiac subjects. The numbers of IELs in the villus tip and sides were counted and the
quotient tip/side was calculated. HLA DQ2/DQ8 and serum antibodies against transglutaminase were analysed.
Results: The mean number of IELs per 100 enterocytes (95% CI) in specimens was 14.7 (11.8-17.6) in the bulb, and
21.2 (17.0-25.5) in the second part of the duodenum (p<0.01). There was no difference in IEL count or distribution
comparing patients carrying or lacking HLA DQ2/DQ8.
Conclusions: IEL count in non-celiac, HLA DQ2/DQ8 positive or negative patients is significantly lower in the bulb
than in the second part of the duodenum. These findings implicate that the site of biopsy should be taken into
account when considering duodenal lymphocytosis.Background
Intraepithelial lymphocytes (IELs) constitute a distinct
population of T cells in the basal portion of the gut
epithelium. Intraepithelial lymphocytosis is one of the
criteria for the diagnosis of celiac disease (CD) [1]. How-
ever, it is an unspecific finding that can be found in
many other inflammatory conditions with or without con-
comitant infection [2,3] and can also be drug-induced [4].
In western countries, intraepithelial lymphocytosis is asso-
ciated with Helicobacter pylori (HP) infection provided
that CD has been excluded [5,6]. In patients with HP-
infection high numbers of IELs in the duodenum [7] de-
crease after HP-eradication [5].
Intraepithelial lymphocytosis was recently defined as a
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reproduction in any medium, provided the orenterocytes in the duodenal mucosa, as judged by im-
munohistochemistry [8]. Increased numbers of IELs has
been considered to be of high diagnostic value in CD,
provided the distribution is even along the villus
[4,9,10] or if the IELs predominantly have an apical lo-
calisation [4,11,12] In recent years, it has been claimed
that biopsies from the bulb are essential when consider-
ing CD [3,13,14], and this is now recommended in
addition to biopsies from the second part of the duode-
num in all patients who are investigated for CD [14-16].
A reference value for IELs in the bulb has not been set-
tled, but it has been assumed to be in the same range as
in the second part of duodenum [6,17].
The aims of this study were to assess (i) the numbers
and distribution of IELs in biopsies from the bulb and
the second part of the duodenum in subjects without
HP (ii) whether there are any differences in numbers or
distribution of IELs between subjects with or without
HLA DQ2/8.ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Study population
Patients successfully treated for non-ulcerating HP gas-
tritis ten years ago were recruited to minimise any
influence of recent HP-infection. A prerequisite was that
they had a negative urea breath test 6 weeks after HP
eradication and, at control gastroscopy one year later, a
negative rapid urease test and no HP present at histo-
logical examination. Further, the study subjects (n=57)
were selected on the basis of available frozen (−70°C)
serum samples (S1), which were analyzed for antibodies
against tissue transglutaminase (anti-tTG) to exclude
CD with high probability. The patients were asked to
participate in a follow-up control with endoscopy. Out
of the 57 identified subjects 23 declined or were dis-
qualified from a new endoscopy due to high age.
The remaining 34 subjects consisted of 14 men and 20
women with a mean age of 66 years (range 37–88). No
patients suffered from any disease known to be associ-
ated with increased IEL except seven subjects who had
regular intake of non-steroidal anti-inflammatory drugs.
All patients underwent blood sampling (S2).
Esophago-duodenoscopy
At the upper gastrointestinal endoscopy two biopsy speci-
mens were taken from the bulb (in all but one case) and
two specimens from the second part of the duodenum
below the papilla major. Biopsies for rapid urease test
(Pronto Dry®, Gastrex, Brignais, France) were taken from
both antrum and corpus [18].
Histopathology
Biopsy specimens from duodenum and the bulb were
fixed in formalin. Paraffin blocks were cut in 4-μm
sections and stained with hematoxyline-eosine (HE) to
assess the villous/crypt ratio and immuno-histochemical
staining (IHC) with anti-CD3 monoclonal antibody (mono-
clonal IgG1 mouse anti-human CD3 antibodies, Clone
F7.2.38. Dako, Glosrup, Denmark) to visualise IELs. The
specimens were independently examined by an experi-
enced pathologist (SI) and a resident (OB). In each speci-
men areas of mostly expressed histopathological changes
including low villus/crypt ratio, increased numbers of lym-
phocytes were recognized. Lymphocytes were estimated in
CD3 immunostained sections counting 500 enterocytes
preferably in five adjacent, well oriented villi. In each of the
five villi the number of IELs per 20 enterocytes in the tip
of the villus and per 80 enterocytes in the side of the villus
(altogether 100 enterocytes per villus) was calculated. An
upper limit of 25 lymphocytes per 100 enterocytes and a
minimal villus/crypt (V:C) ratio of 3:1 in the second part
of the duodenum were considered normal [19]. A value
of top-IELs/100 enterocytes (five villi) and side IELs/
400 enterocytes (five villi) converted to IELs number/100 enterocytes was tabulated. Furthermore, IELs tip/
side score (T/S) was calculated in order to distinguish
IELs distribution pattern.
Serum analyses
Ten year old (S1) and new (S2) serum samples were exam-
ined regarding IgA-antibodies against human recombinant
tTg (Celikey, Phadia, Freiburg, Germany). The analyses
were performed according to the manufacturers’ instruc-
tions and the recommended cut-off 7 AU⁄ mL was used.
Total serum IgA levels were determined by a routine tur-
bidimetric method. One patient had developed an IgA-
deficiency (<0.07 g/L) in the S2 blood sampling, and in
this case IgG anti-tTg was analysed.
HLA
Typing for DQ2/DQ8 genes was performed with PCR-SSP
assay (Olerup SSP®, Wien, Austria).
Statistical analysis
Kappa statistics was used to compare histological classi-
fication between the two examiners. The study results
were depicted by mean and 95% confidence interval (CI).
Comparisons were performed by the t-test. P-values below
0.05 (2-sided) were considered statistically significant.
Ethical considerations
The study was approved by the regional ethics committee
(Regionala etikprövningsnämnden i Linköping), Linköping,
Sweden. All subjects gave written informed consent.
Results
HP status
Based on a negative rapid urease test (performed during
gastroenteroscopy using biopsy specimens both from the
antrum and the corpus) together with negative histology
for HP, a current HP infection was excluded in all but
one case.
Serology
The S1 serum samples as well as the S2 follow-up serum
samples were all negative regarding anti-tTG antibodies.
Histology
The specimen from the patient with recurrent HP infec-
tion was excluded. One patient did not have a biopsy
from the bulb taken and one biopsy from the bulb was
not possible to examine due to inadequate preparation.
The inter-observer results were consistent (kappa co-
efficient 0.67 and 0.69 respectively) regarding histopath-
ology of the bulb (n=31) and the second part of the
duodenum (n=33). The IELs values of OB were chosen
for statistical analyses.
Table 1 Intraepithelial lymphocytosis in specimens from the second part of the duodenum and from the bulb
IELs/ 100 enterocytes Tip Side Total T/S
Duodenum 23.0* (19.5-26.5) 21.2* (16.7-25.6) 21.6* (17.5-25.8) 1.26 (1.07-1.44)
Bulb 15.9* (12.0-19.8) 14.0* (11.1-16.9) 14.3* (11.4-17.1) 1.24 (1.06-1.43)
* p<0.01
Tip- the sum of IEL/20 enterocytes from five villi.
Side- the sum of IEL/80 enterocytes from five villi divided by four.
Total- the sum of five villi’s IEL/20 enterocytes in the tip + IEL/80 enterocytes in the side divided by five.
T/S the number of tip enterocytes divided by the number of side enterocytes.
Mean values and 95% CI.
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enterocytes, corresponding to Marsh grade I) was found
in 27% of duodenal biopsies and in 13% of bulb biopsies
(p>0.05).
No biopsy revealed crypt hyperplasia. The villus:crypt-
ratio was significantly lower in the bulb compared with
the duodenal biopsies (mean 2.3 and 3.1 respectively,
p<0.001).
The number of IELs in biopsies from the second part
of the duodenum were significantly higher (p<0.01) than
in biopsies from the bulb, both in the tip and the side, as
well as regarding total IEL counts (Table 1). The ‘IEL dis-
tribution pattern’, IEL tip/side score, in the second part of
the duodenum did not differ significantly from that in the
bulb (Table 1).
Subjects regularly using NSAID (n=7) had a tendency
(p=0.07) of a higher IEL count in the second part of the
duodenum mean 29.1 (95% CI, 11.9-46.2) compared with
subjects not using NSAID 19.6 (95% CI, 16.1-23.1).
HLA genotyping
The HLA DQ2 and/or DQ8 were found in 41%.
IEL counts did not differ between patients with or
without HLA DQ2/8 (Table 2).
Discussion
The importance of taking biopsies from the bulb in the
diagnostic workup of celiac disease has been reported
lately [13-16,20]. There is no established cut-off value
for increased number of IELs in the bulb. Whether or
not intraepithelial lymphocytosis is restricted to the bulbTable 2 Number of IELs per 100 enterocytes in the second pa
without HLADQ2/8
IELs/100 enterocytes Tip Side
DQ2/8 duodenum 22.1 (14.9-29.2) 21.5
Non-DQ2/8 duodenum 23.6 (19.6-27.6) 20.9
DQ2/8 bulb 16.8 (7.9-25.7) 14.0
Non-DQ2/8 bulb 15.3 (11.9-18.6) 14.0
Tip- the sum of IEL/20 enterocytes from five villi.
Side- the sum of IEL/80 enterocytes from five villi divided by four.
Total- the sum of five villi’s IEL/20 enterocytes in the tip + IEL/80 enterocytes in the
T/S the number of tip enterocytes divided by the number of side enterocytes.
Mean values and 95% CI.in early stages of CD is not known. Most publications in
this field evaluate the number of IELs in the second part
of the duodenum [19], and these results have automatic-
ally been considered to apply also for the bulb.
We found IEL counts to be significantly lower in the
bulb compared to the second part of the duodenum.
There are a few previous reports on the number of IELs
in the bulb compared with the second part of the duode-
num in children and adults without CD, and in these stud-
ies no significant differences were found [6,13,17,21]. The
lower IEL counts in the bulb reported here might be of
importance when defining intraepithelial lymphocytosis in
specimens from this area, as the accepted cut-off in the
second part of the duodenum i.e. >25 IELs per 100
enterocytes may be too high for the bulb. Our findings
indicate that different cut-off levels should be applied in
the bulb compared with the distal duodenum, to define
intraepithelial lymphocytosis at these sites. This may be
important in order not to underestimate intraepithelial
lymphocytosis in cases where duodenal biopsies are only
available from the bulb.
HLA DQ2 and DQ8 are closely linked to CD [22], but
seems also to be overrepresented in HP infection [23].
Hence, the high occurrence of these HLA alleles among
our subjects with previous HP-infection was expected.
In this study, IEL counts did not differ between patients
with or without DQ2/8. In order to obtain reference
values for IELs in true non-CD, biopsies from the second
part of duodenum have recently been explored in DQ2/8-
negative controls [24]. The optimal approach might be to
define IEL cut-off levels based on biopsies from healthyrt of the duodenum and in the bulb in patients with and
Total T/S
(11.1-31.9) 21.8 (12.2-31.5) 1.27 (0.90-1.63)
(16.7-25.2) 21.5 (17.5-25.4) 1.25 (1.03-1.46)
(9.0-19.0) 14.2 (8.8-19.6) 1.28 (0.92-1.64)
(10.0-17.9) 14.3 (10.7-17.9) 1.22 (0.99-1.45)
side divided by five.
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ther had latent or silent CD nor an active or recent HP in-
fection, we selected cases who had no clinical signs of
gluten intolerance and negative anti-tTg antibody tests
also at follow-up after a ten year observation period., As
IEL counts were the same in cases with or without DQ2/
DQ8, it seems justified to apply the same reference value
regardless of HLA DQ2/DQ8 status.
The microscopic examination of biopsy specimens
from both the bulb and the second part of the duode-
num, overall revealed an even IEL distribution along the
villus, but with a tendency of increased IEL counts
apically. We performed an exact enumeration of IELs, in
contrast to the observer-dependent estimation which
has been applied so far [25]. Until now, only one study
has reported a duodenal IEL ratio by dividing IEL counts
in the villus tip with IEL counts at the side of the villus
[12]. The results of the present study argue against the
prevailing notion that an apical predominance or ’even-
along-the-villus’ pattern is a finding suggestive of CD
[4,9,10,26], since we found that this was common also
among non-CD subjects.
A major drawback of this study is the limited study
population. However, this was due to our wish to ex-
clude CD cases by a 10-year follow-up of subjects testing
negative with regard to celiac-specific antibodies. There-
fore, identification of stored serum samples was crucial
for the study but at the same time a limiting condition,
especially as we also wished to include patients with
HLA DQ2/8 i.e. those with a genetic prerequisite to de-
velop CD [22]. Despite the limitation, this long observa-
tion time is at the same time a major advantage of our
study. Another study virtue is the high kappa coefficient
value of the IEL counts reported by the two independent
investigators, reassuring the reliability of our results.
Conclusion
In this study we found (i) lower number of IELs in the
bulb compared with the second part of the duodenum
in subjects without any sign of CD. The distribution of
IELs was the same in bulb and the second part of the
duodenum. (ii) There was no difference in number or
distribution of IELs between subjects regardless of HLA-
DQ2 or -DQ8 occurrence.
Our findings implicate that the approach to evaluate
duodenal lymphocytosis needs deeper appreciation with
regard to whether specimens from the bulb or the de-
scending part of the duodenum are examined.
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